European Alzheimers Disease Medication Market

Launch of Disease-modifying Drugs expected to Boost Market Growth

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The key objective of this research service  is to study the European Alzheimer’s disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments.  It also aims to provide valuable insights on the potential drug candidates in the pipeline  and analyse the competitive landscape  with respect to the key existing market participants and promising companies in the future. Revenue forecasts of total market as well as key five European countries is also provided.

Table of Contents

European Alzheimer's Disease Medication Market, European Alzheimer's Disease Medication MarketExecutive SummaryExecutive SummaryMarket OverviewMarket Overview-DefinitionsMarket Overview - Key Questions This Study Will AnswerMarket OverviewKey Timeline of EventsCentral Nervous System (CNS) Disorder SegmentationMarket SegmentationMarket Overview - SegmentationGeographic ScopeGeographic SegmentationIntroduction to Alzheimer's DiseaseDisease OverviewPathophysiologyDisease StagingRisk FactorsDiagnosisKey Areas of R&DEpidemiologyDementia PrevalenceDementia Patients - ForecastsTreatment StatisticsExternal Challenges: Drivers and Restraints - Total Alzheimer's Disease Medication MarketMarket Drivers and RestraintsMarket Drivers - ExplainedMarket Restraints - ExplainedImpact Mapping of Drivers and RestraintsRevenue Forecast - Total Alzheimer's Disease Medication MarketEuropean Alzheimer's Disease Medication Market - Market Engineering MeasurementsForecast AssumptionsEuropean Alzheimer's Disease Medication Market - Revenue ForecastEuropean Alzheimer's Disease Medication Market - Revenue Forecast DiscussionMarket Share and Competitive Analysis - Total Alzheimer's Disease Medication MarketCompetitive Analysis - Market ShareMarket Share AnalysisCompetitive EnvironmentCompetitive Analysis: Profiling of Selected Key Market ParticipantsCompetitive Analysis: Most Promising Companies in the FutureTop CompetitorsCompetitor Growth AnalysisAlzheimer's Disease Medication Market Competitive LandscapeMarketed Product AnalysisEMEA Approved Drugs for Alzheimer's DiseaseAriceptExelon/ Exelon PatchReminylEbixaDosing RegimenPipeline AnalysisPipeline OverviewPipeline Analysis by Clinical PhasePipeline Analysis by Mechanism of ActionKey Pipeline Drug Candidates by Mechanism of ActionPromising Late-stage Drug CandidatesLate-stage Failed Drug Candidates Cost Analysis and Disease BurdenCosts of DementiaCosts of Dementia - ForecastCost AnalysisDisease BurdenRegulatory AnalysisThe European Union Regulatory Framework for Alzheimer's DiseaseDiagnostic CriteriaTherapeutic Efficacy CriteriaMeasurement ToolsGeneral StrategyGeriatric RequirementsAcetylcholinesterase Inhibitors Segment BreakdownAcetylcholinesterase Inhibitors OverviewAcetylcholinesterase Inhibitors Mechanism of ActionMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionEnd-user AnalysisPhysician's PerceptionNMDA Receptor Antagonists Segment BreakdownNMDA Receptor Antagonists OverviewNMDA Receptor Antagonists Mechanism of ActionMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionEnd-user AnalysisPhysician's PerceptionDisease-modifying Drugs Segment BreakdownDisease-modifying Drugs OverviewDisease-modifying Drugs Mechanism of ActionMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionGerman Alzheimer's Disease Medication MarketGermany-Market Engineering MeasurementsGermany-Revenue ForecastRegulatory Framework - Treatment Access and Reimbursement of DrugsFrench Alzheimer's Disease Medication MarketFrance-Market Engineering MeasurementsFrance-Revenue ForecastRegulatory Framework - Treatment Access and Reimbursement of DrugsThe United Kingdom Alzheimer's Disease Medication MarketThe United Kingdom-Market Engineering MeasurementsThe United Kingdom-Revenue ForecastRegulatory Framework - Treatment Access and Reimbursement of DrugsItalian Alzheimer's Disease Medication MarketItaly-Market Engineering MeasurementsItaly-Revenue ForecastRegulatory Framework - Treatment Access and Reimbursement of DrugsSpanish Alzheimer's Disease Medication MarketSpain-Market Engineering MeasurementsSpain-Revenue ForecastRegulatory Framework - Treatment Access and Reimbursement of DrugsThe Last WordThe Last Word -Three Big PredictionsAppendixMarket Engineering MethodologyList of Key European Alzheimer's Disease Networking OrganisationsAdditional Sources of Information Related to Alzheimer's Disease Medication MarketTable of Acronyms UsedDatabase of Key Industry ParticipantsDecision Support Databases




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.